Body clock may predict asthma attacks
NCT ID NCT06302959
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether proteins that control our body's daily rhythms (clock proteins) can predict how severe asthma will get. Researchers monitored these proteins in the blood and sputum of 50 adults with severe eosinophilic asthma before and during treatment with mepolizumab. The goal was to see if clock proteins could serve as a marker for disease progression or treatment success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Graz
Graz, Styria, 8010, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Beyond breathing: could an asthma drug lift emotional burdens for patients and partners?
- Smart inhalers track Fasenra's asthma control over full dosing cycle
- CT scan could predict asthma drug success, saving months of trial and error
- New asthma drug shows promise in real-world greek study
- Real-World study checks if benralizumab tames severe asthma in taiwan
- Severe asthma drug may boost daily steps, study hopes